FMT
Studies ID Predictors of FMT Failure, Infection Recurrence in Patients With CDI
Researchers have identified a number of risk factors for treatment failure after fecal microbiota transplantation ...
SEPTEMBER 8, 2021
AGA Registry Analysis Confirms Utility of FMT for Recurrent C. difficile
Initial findings from the American Gastroenterological Association Fecal Microbiota Transplantation National ...
DECEMBER 16, 2020
FDA Fast-Tracks FMT Product for C. difficile
The FDA awarded a fast track designation for CP101, an encapsulated, oral fecal microbiota transplant product by ...
APRIL 2, 2018
New C. difficile Guidelines Recommend New Treatment, Testing Protocols
CDI affects nearly 500,000 Americans every year, resulting in 15,000 to 30,000 deaths and costing more than $4.8 ...
FEBRUARY 15, 2018
Load more